NasdaqCM - Nasdaq Real Time Price USD

Estrella Immunopharma, Inc. (ESLA)

1.0473
-0.0627
(-5.65%)
As of 1:12:03 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
8,816.3380
7,310.0980
11,114.4020
1,685.3470
733.6930
Operating Income
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Pretax Income
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Tax Provision
1.6250
1.6250
0
0
0
Net Income Common Stockholders
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Diluted NI Available to Com Stockholders
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Basic EPS
-0.24
-0.27
-0.32
-0.05
-0.02
Diluted EPS
-0.24
-0.27
-0.32
-0.05
-0.02
Basic Average Shares
36,190.8960
27,103.9640
35,201.2320
35,201.2320
35,201.2320
Diluted Average Shares
36,190.8960
27,103.9640
35,201.2320
35,201.2320
35,201.2320
Total Operating Income as Reported
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Total Expenses
8,816.3380
7,310.0980
11,114.4020
1,685.3470
733.6930
Net Income from Continuing & Discontinued Operation
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Normalized Income
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
EBIT
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
EBITDA
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Net Income from Continuing Operation Net Minority Interest
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Normalized EBITDA
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 9/14/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers